Back

126 Views

Favorite
Print

Clinical Session Proposals

EMG/Neuromuscular

Session Name: Decision Making in the Use of FDA Approved Treatments for Spinal Muscular Atrophy

1 - Review of Spinal Muscular Atrophy

Friday, October 21, 2022

2:00 PM – 3:15 PM ET

Location: 318-323

Speaker(s)

Susan D. Apkon, MD (she/her/hers)

Fishchahs Chair in Pediatric Rehabilitation
Childrens Hospital Colorado
Aurora, Colorado

Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

PDF of Slides

Dr. Apkon will briefly review the different types of spinal muscular atrophy and the pathophysiology of the disease. She will also facilitate the panel discussion using a case presentation format.

Learning Objectives:

List the 4 types of spinal muscular atrophy
Describe mechanism of action of the 3 FDA approved drugs to treat spinal muscular atrophy